Hosted on MSN
Statin debate intensifies as new data emerge
Recent research and updated cholesterol guidelines are reshaping the conversation about statins, their benefits, and possible long-term effects. While leading cardiology organizations reaffirm their ...
A new Lancet study says statin side effects are overblown. Headlines are running that millions more people should be taking ...
Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. It’s a math problem with life-and-death ...
Statins, which are prescription drugs that can reduce cholesterol levels and lower the risk for heart disease, don’t affect kidney function, new research shows. Investigators found that taking a ...
EAST HANOVER, N.J., April 6, 2024 /PRNewswire/ -- Novartis today announced new data demonstrating the early addition of twice-yearly* Leqvio ® (inclisiran) to maximally tolerated statin therapy, prior ...
Statin use is linked to better survival in breast cancer, observational data from Taiwan suggest. Yet researchers only saw a difference for all-cause and cancer-related deaths, not CV death. The ...
Far fewer people who could benefit from statins actually take the cholesterol-lowering drugs now. Many who start taking them stop. The long list of side effects, detailed in fine print on package ...
The polypill offers a cost-effective solution for CVD management in underserved populations, potentially reducing health disparities. The intervention is projected to cost $8560 per QALY gained, ...
HKUMed demonstrates that statins can lower the risk of cardiovascular disease without increasing major adverse events, providing guidance for future clinical practice in managing high cholesterol. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results